Muszbek L, Haramura G, Polgár J
Department of Clinical Chemistry, University School of Medicine, Debrecen, Hungary.
Thromb Haemost. 1995 Apr;73(4):702-5.
The cellular form of blood coagulation factor XIII (FXIII) is present in platelets, monocytes and macrophages. During long-term stimulation of platelets by thrombin cellular FXIII becomes activated and cross-links proteins, however, the mechanism of its activation has not been elucidated. It was shown that, contrary to plasma FXIII, the intracellular activation of platelet FXIII does not involve proteolysis. FXIII remained intact in thrombin-activated platelets, i.e., the activation peptide was not removed from the molecule. Part of the zymogen FXIII molecules, however, assumed an active configuration as was demonstrated both by the measurement of transglutaminase activity and by active-site-SH titration. These findings clearly indicate that during platelet activation, when intracellular Ca2+ concentration is raised, a slow non-proteolytic transformation of FXIII zymogen into an active transglutaminase occurs.
血液凝固因子 XIII(FXIII)的细胞形式存在于血小板、单核细胞和巨噬细胞中。在凝血酶对血小板进行长期刺激的过程中,细胞内的 FXIII 被激活并使蛋白质交联,然而,其激活机制尚未阐明。研究表明,与血浆 FXIII 不同,血小板 FXIII 的细胞内激活不涉及蛋白水解。FXIII 在凝血酶激活的血小板中保持完整,即激活肽未从分子上移除。然而,通过转谷氨酰胺酶活性测定和活性位点 - SH 滴定均表明,部分 FXIII 酶原分子呈现出活性构型。这些发现清楚地表明,在血小板激活过程中,当细胞内 Ca2+ 浓度升高时,FXIII 酶原会缓慢地发生非蛋白水解转化,形成有活性的转谷氨酰胺酶。